Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Adverse effects of Δ9-tetrahydrocannabinol on neuronal bioenergetics during postnatal development
Johannes Beiersdorf, Zsofia Hevesi, Daniela Calvigioni, Jakob Pyszkowski, Roman Romanov, Edit Szodorai, Gert Lubec, Sally Shirran, Catherine H. Botting, Siegfried Kasper, Geoffrey W. Guy, Roy Gray, Vincenzo Di Marzo, Tibor Harkany, Erik Keimpema
Johannes Beiersdorf, Zsofia Hevesi, Daniela Calvigioni, Jakob Pyszkowski, Roman Romanov, Edit Szodorai, Gert Lubec, Sally Shirran, Catherine H. Botting, Siegfried Kasper, Geoffrey W. Guy, Roy Gray, Vincenzo Di Marzo, Tibor Harkany, Erik Keimpema
View: Text | PDF
Research Article Cell biology Development

Adverse effects of Δ9-tetrahydrocannabinol on neuronal bioenergetics during postnatal development

  • Text
  • PDF
Abstract

Ongoing societal changes in views on the medical and recreational roles of cannabis increased the use of concentrated plant extracts with a Δ9-tetrahydrocannabinol (THC) content of more than 90%. Even though prenatal THC exposure is widely considered adverse for neuronal development, equivalent experimental data for young age cohorts are largely lacking. Here, we administered plant-derived THC (1 or 5 mg/kg) to mice daily during P5–P16 and P5–P35 and monitored its effects on hippocampal neuronal survival and specification by high-resolution imaging and iTRAQ proteomics, respectively. We found that THC indiscriminately affects pyramidal cells and both cannabinoid receptor 1+ (CB1R)+ and CB1R– interneurons by P16. THC particularly disrupted the expression of mitochondrial proteins (complexes I–IV), a change that had persisted even 4 months after the end of drug exposure. This was reflected by a THC-induced loss of membrane integrity occluding mitochondrial respiration and could be partially or completely rescued by pH stabilization, antioxidants, bypassed glycolysis, and targeting either mitochondrial soluble adenylyl cyclase or the mitochondrial voltage-dependent anion channel. Overall, THC exposure during infancy induces significant and long-lasting reorganization of neuronal circuits through mechanisms that, in large part, render cellular bioenergetics insufficient to sustain key developmental processes in otherwise healthy neurons.

Authors

Johannes Beiersdorf, Zsofia Hevesi, Daniela Calvigioni, Jakob Pyszkowski, Roman Romanov, Edit Szodorai, Gert Lubec, Sally Shirran, Catherine H. Botting, Siegfried Kasper, Geoffrey W. Guy, Roy Gray, Vincenzo Di Marzo, Tibor Harkany, Erik Keimpema

×

Figure 2

Long-lasting alterations in the mouse hippocampal proteome upon THC exposure identify a mitochondrial site of vulnerability.

Options: View larger image (or click on image) Download as PowerPoint
Long-lasting alterations in the mouse hippocampal proteome upon THC expo...
(A) Schematic illustration of the analysis pipeline. THC and vehicle were administered daily during the period of P5–P35. Tissue collection was on either P48 or P120 (n = 5 fetuses/group/time point from independent pregnancies) followed by iTRAQ proteomics. (B) Graphical illustration of the functional assignment of protein targets to gene ontology (GO; https://www.uniprot.org) clusters on P48 or P120. (C) Representative Western blot colabeled for molecular constituents of the 5 mitochondrial respiratory chain complexes on P48 and P120 (such as NADH dehydrogenase [ubiquinone] 1 β subcomplex subunit 8 (NDUFB8; complex I [CI]); succinate dehydrogenase [ubiquinone] iron-sulfur subunit [SDHB; CI]); cytochrome b-c1 complex subunit 2 [UQCRC2; CIII]; cytochrome c oxidase subunit 1 [MTCO1; CIV]; and ATP synthase subunit α [ATP5A; CV]). Cy5 dye labeling was used to normalize protein load (Supplemental Figure 5). (D) Cumulative Western blot results on the levels of the mitochondrial oxidative phosphorylation (OXPHOS) machinery. (E) TOM20 immunoreactivity in cortical neurons detected by laser-scanning microscopy (upper). Synaptobrevin (Synbrev) was used as a presynaptic/axonal marker. Subsequently, super-resolution microscopy (Zeiss ELYRA) confirmed the localization of TOM20 in mitochondria (lower). (F) Representative Western blots labeled for TOM20 (or total protein load; Supplemental Figure 5) at P48 or P120. (G) Quantitative data are from n ≥ 3 animals/group. Data were expressed as mean ± SEM; *P < 0.05 (versus control; 1-way ANOVA followed by Bonferroni’s post hoc test). Scale bars: 20 μm (E, upper), 500 nm (E, lower).

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts